Results 301 to 310 of about 2,497,858 (389)
Abstract INTRODUCTION Adults with Down syndrome (DS) display increased Alzheimer's disease (AD) risk. The cholinergic system declines early in the AD continuum and relates to cognitive and functional decline. We aimed to identify the timeline of cholinergic decline in relation to hippocampal atrophy within the AT(N) framework in DS.
Jason K. Russell +7 more
wiley +1 more source
Abstract INTRODUCTION With the approval of lecanemab for treating Alzheimer's disease (AD), there is an urgent need to evaluate its safety and treatment effects on biomarkers in real‐world practice. METHODS Patients receiving lecanemab (n = 72) underwent routine 3T and 7T magnetic resonance imaging (MRI) for amyloid‐related imaging abnormality (ARIA ...
Weiwei Zhang +12 more
wiley +1 more source
Inflammation in the Transition Period of Dairy Cows: New Paradigms. [PDF]
Fritzen A, da Silva AS.
europepmc +1 more source
Abstract INTRODUCTION The basal forebrain (BF), a key cholinergic hub, undergoes atrophy in Alzheimer's disease (AD), contributing to cognitive decline. However, its age‐related differences and early vulnerability in autosomal dominant AD (ADAD) remain unclear.
Bing He +18 more
wiley +1 more source
Impact of pesticide diazinon on gastric cancer cell lines and the alteration of cholinergic and serotonergic pathway genes affecting cell proliferation. [PDF]
Ghaemi S +3 more
europepmc +1 more source
Cholinergic modulation mediates attentional mechanism to enhance coherence between cortical layers in macaque V1 and V4. [PDF]
Sajedin A +2 more
europepmc +1 more source
Complex opioid-driven modulation of glutamatergic and cholinergic neurotransmission in a GABAergic brain nucleus associated with emotion, reward, and addiction. [PDF]
Chittajallu R +8 more
europepmc +1 more source

